Colistin: An Antimicrobial for the 21st Century?
Open Access
- 1 October 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (7) , 901-902
- https://doi.org/10.1086/342570
Abstract
Sir —The emergence of multidrug-resistant, gram-negative bacteria that cause nosocomial infection is a growing problem worldwide. Strains of Pseudomonas aeruginKeywords
This publication has 4 references indexed in Scilit:
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999
- Ambulatory Treatment of Multidrug-Resistant Staphylococcus -Infected Orthopedic Implants with High-Dose Oral Co-trimoxazole (Trimethoprim-Sulfamethoxazole)Antimicrobial Agents and Chemotherapy, 1998
- A reassessment of the in-vitro activity of colistin sulphomethate sodiumJournal of Antimicrobial Chemotherapy, 1997
- Binding of Polymyxin Antibiotics to Tissues: The Major Determinant of Distribution and Persistence in the BodyThe Journal of Infectious Diseases, 1971